S. Karger AG

SHERPA: Unknown

People

  1. Ilson
    Ilson

Groups

  1. Department of Medicine (4)
  2. Gastrointestinal Oncology Service (4)
  3. Solid Tumor Oncology Division (4)
Search Within
  1. "David Ilson"
Formats
  1. Meeting Abstract (4)
Groups
  1. Department of Medicine (4)
  2. Gastrointestinal Oncology Service (4)
  3. Solid Tumor Oncology Division (4)
People
  1. David Ilson (4)
Years
  1. 2023 (2)
  2. 2021 (1)
  3. 2019 (1)
Publications
  1. Oncology Research and Treatment (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Zolbetuximab + CAPOX in 1L Claudin-18.2+(CLDN18.2+)/HER2-locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW
    Meeting Abstract

    Lordick, F.; Xu, R. H.; Shitara, K.; Ajani, J. A.; Bang, Y. J.; Enzinger, P.; Ilson, D.; Van Cutsem, E.; Plazas, J. G.; Huang, J.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Zolbetuximab+mFOLFOX6 as first-line (1L) treatment for patients (Pts) with claudin-18.2+(CLDN18.2+) / HER2-locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary results from phase 3 SPOTLIGHT study
    Meeting Abstract

    Lordick, F.; Shitara, K.; Bang, Y. J.; Enzinger, P.; Ilson, D.; Shah, M. A.; Van Cutsem, E.; Xu, R. H.; Aprile, G.; Xu, J.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Spotlight: Phase 3 study of Zolbetuximab+mFOLFOX6 versus placebo+mFOLFOX6 in first-line claudin18.2(+)/HER2(-) advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)
    Meeting Abstract

    Lordick, F.; Shitara, K.; Al-Batran, S. E.; Bang, Y. J.; Catenacci, D.; Enzinger, P.; Ilson, D.; Kim, S.; Shah, M. A.; Van Cutsem, E.; more...
    Oncology Research and Treatment (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastric cancer (mGC) with or without prior gastrectomy: Results from a phase III study (TAGS)
    Meeting Abstract

    Thuss-Patience, P.; Lorenzen, S.; Ettrich, T.; Karthaus, M.; Ilson, D. H.; Prokharau, A.; Arkenau, H. T.; Ghidini, M.; Fujitani, K.; Van Cutsem, E.; more...
    Oncology Research and Treatment (2019)

    Fulltext@MSK | Save